LIU, Jialu, SOLANKI, Ani, WHITE, Michael J. V., HUBBELL, Jeffrey A. und BRIQUEZ, Priscilla S., 2022. Therapeutic use of α2-antiplasmin as an antifibrinolytic and hemostatic agent in surgery and regenerative medicine. Freiburg: Universität.
Elsevier - Harvard (with titles)Liu, J., Solanki, A., White, M.J.V., Hubbell, J.A., Briquez, P.S., 2022. Therapeutic use of α2-antiplasmin as an antifibrinolytic and hemostatic agent in surgery and regenerative medicine. Universität, Freiburg. https://doi.org/10.1038/s41536-022-00230-x
American Psychological Association 7th editionLiu, J., Solanki, A., White, M. J. V., Hubbell, J. A., & Briquez, P. S. (ca. 2022). Therapeutic use of α2-antiplasmin as an antifibrinolytic and hemostatic agent in surgery and regenerative medicine [Cd]. Universität. https://doi.org/10.1038/s41536-022-00230-x
Springer - Basic (author-date)Liu J, Solanki A, White MJV, Hubbell JA, Briquez PS (2022) Therapeutic use of α2-antiplasmin as an antifibrinolytic and hemostatic agent in surgery and regenerative medicine. Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Liu, Jialu/ Solanki, Ani/ White, Michael J. V./ Hubbell, Jeffrey A./ Briquez, Priscilla S., Therapeutic use of α2-antiplasmin as an antifibrinolytic and hemostatic agent in surgery and regenerative medicine, Freiburg 2022.